Antimicrobial activity of apramycin formulated with dextran-based single-chain polymeric nanoparticles against Acinetobacter baumannii

The global emergence of antimicrobial resistance is driving the development of novel strategies for treating bacterial infections. In this context, dextran-based single-chain polymeric nanoparticles (DXT-SCPNs) have been developed as antibiotic delivery systems for the treatment of pulmonary infections. A series of DXT-SCPNs were formulated with apramycin with different physicochemical properties, namely three degrees of substitution (with a low degree of crosslinking in all cases): low (L-DS a ), medium (M-DS a ), or high (H-DS a ), and two degrees of crosslinking (with a medium degree of substitution in both nanoparticles): low (M-DSa) or high (H-CL a ). Their in vitro activity against eleven Acinetobacter baumannii clinical isolates was assessed compared to the free drug, using minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC) and time-kill kinetic (TKK) assays. Overall, no statistically significant differences were observed between the antimicrobial activity of free and formulated apramycin. Nevertheless, a slight trend towards higher activity was observed in the cases of M-DS a and H-CL a .

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-15
DOI
https://doi.org/10.1038/s41598-026-79821-3
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Antimicrobial activity of apramycin formulated with dextran-based single-chain polymeric nanoparticles against Acinetobacter baumannii

José María Marimón, Julie Movellan, Iraida Loinaz, Damien Dupin et al.
Scientific Reports
Nanoparticle-Based Drug Delivery
article

Antimicrobial activity of apramycin formulated with dextran-based single-chain polymeric nanoparticles against Acinetobacter baumannii

José María Marimón, Julie Movellan, Iraida Loinaz, Damien Dupin, Jose Carlos Ibañez Ramos
article en

Abstract

The global emergence of antimicrobial resistance is driving the development of novel strategies for treating bacterial infections. In this context, dextran-based single-chain polymeric nanoparticles (DXT-SCPNs) have been developed as antibiotic delivery systems for the treatment of pulmonary infections. A series of DXT-SCPNs were formulated with apramycin with different physicochemical properties, namely three degrees of substitution (with a low degree of crosslinking in all cases): low (L-DS a ), medium (M-DS a ), or high (H-DS a ), and two degrees of crosslinking (with a medium degree of substitution in both nanoparticles): low (M-DSa) or high (H-CL a ). Their in vitro activity against eleven Acinetobacter baumannii clinical isolates was assessed compared to the free drug, using minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC) and time-kill kinetic (TKK) assays. Overall, no statistically significant differences were observed between the antimicrobial activity of free and formulated apramycin. Nevertheless, a slight trend towards higher activity was observed in the cases of M-DS a and H-CL a .

Scientific Reports
University of the Basque Country (ES), Biogipuzkoa Health Research Institute (ES), Centre for Electrochemical Technologies (ES), Donostiako Unibertsitate Ospitalea (ES)
Good health and well-being
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Antimicrobial activity of apramycin formulated with dextran-based single-chain polymeric nanoparticles against Acinetobacter baumannii — José María Marimón, Julie Movellan, et al. · Scientific Reports (2026) | TGRS Research Map | TGRS